Surmodics, Inc. · 3 hours ago
Territory Manager - DC
BiotechnologyChemical
Insider Connection @Surmodics, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Create an execute effective business plans to meet and achieve sales objectives (revenue, product launches, etc.)
Strategically and effectively launch multiple new products/product lines across geography
Strengthen relationship/partnership with existing accounts while building strong relationship with new customers
Train customers and support cases to ensure appropriate use of SRDX products
Maintain appropriate tracking of SRDX products, to include consignment and rep stock inventory
Complete all required training and maintain required documentation (customer complaints, vendor credentialing, etc.)
Responsible for quarterly/annual forecasting of regional revenues
Act in compliance with all laws and company rules and regulations
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
B.S. or B.A. degree, preferably in business, engineering or science-related field and/or healthcare degree or certification (i.e. nursing or technologist background)
5+ years experience in medical device sales/clinical support, training, marketing or related clinical experience; cardiovascular experience preferred
Strong written and verbal communication, interpersonal skills
Computer skills appropriate for work responsibilities, including CRM software experience
Willingness to travel (up to 75%, dependent on territory), flexibility to accommodate a schedule that changes on short notice due to customer needs
Preferred
Cardiovascular experience
Benefits
Competitive compensation and benefits package
Bonus program
401(k) with employer match
Employee stock purchase plan
Stock options
Company
Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays.
Funding
Current Stage
Public CompanyTotal Funding
$125MKey Investors
MidCap Financial
2024-05-29Acquired
2022-10-17Post Ipo Debt· $125M
1998-03-04IPO
Leadership Team
Recent News
2024-05-31
2024-05-30
Medical Product Outsourcing
2024-05-29
Company data provided by crunchbase